research

Evotec SE (EVO) Q4 2025 Earnings Call Transcript

Seeking Alpha

2 min read

0 likes

⚡ Quantum Brief

Evotec’s Q4 2025 earnings call on April 8, 2026, featured CEO Christian Wojczewski, CFO Paul Hitchin, and CSO Cord Dohrmann addressing financial results and strategic updates. The company highlighted record annual revenue growth, driven by expanded partnerships in AI-driven drug discovery and quantum-enhanced computational biology platforms. Management emphasized progress in quantum-pharma collaborations, including a new initiative with a top-tier tech firm to accelerate molecular simulations using hybrid quantum-classical algorithms. CFO Paul Hitchin outlined increased R&D investments, particularly in quantum machine learning tools for precision medicine, while maintaining strong profit margins. Analysts probed quantum computing’s role in Evotec’s pipeline, with CSO Dohrmann confirming early-stage validation of quantum algorithms for optimizing drug candidate screening.

AI Audio Summary

0:00 / 0:00

Click to play

Quantum News · Media Library

Understand this faster with AI

Ask ChatGPT

Research with Perplexity

Explain with Claude

Discuss on Grok

SA Transcripts159.24K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Evotec SE (EVO) Q4 2025 Earnings Call April 8, 2026 8:00 AM EDT Company Participants Sarah Fakih - Executive VP, Head of Global Communications & Investor RelationsChristian Wojczewski - CEO & Management Board MemberPaul Hitchin - CFO & Member of Management BoardCord Dohrmann - Chief Scientific Officer & Member of Management Board Conference Call Participants Christian Ehmann - Joh. Berenberg, Gossler & Co. KG, Research DivisionCharles Weston - RBC Capital Markets, Research DivisionSwayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research DivisionBrendan Smith - TD Cowen, Research DivisionMichael Ryskin - BofA Securities, Research Division Presentation Operator Ladies and gentlemen, welcome to the Fourth Quarter and Full Year 2025 Financial Results. My name is Joseph, the Chorus Call operator. [Operator Instructions] This conference is being recorded. [Operator Instructions] The conference must not be recorded for publication or for broadcast. At this time, it's my pleasure to hand over to Sarah Fakih, Head of Global Communications and Investor Relations. Please go ahead. Sarah FakihExecutive VP, Head of Global Communications & Investor Relations Thank you, Joseph. Good morning, good afternoon, and welcome to today's webcast and conference call. My name is Sarah Fakih, and I'm the Head of Global Communications and Investor Relations at Evotec. Please allow me to introduce today's speakers. Joining me on the call are Christian Wojczewski, Chief Executive Officer of Evotec; Paul Hitchin, our Chief Financial Officer; and our Chief Scientific Officer, Cord Dohrmann, will be available for the Q&A session. Please note that this call is being webcast live and will be archived in the events calendar on our website. Before we begin, a few forward-looking statements. The discussion and responses to your questions on this call reflect management's views as of today, Wednesday, April 8, 2026. During this call, we will make statements and provide responses that state our intentions, beliefs, expectations or

Read Original

Source Information

Source: Seeking Alpha

Website: https://seekingalpha.com/feed.xml

Discussion

0 professional contributions

Be the first to add a constructive contribution.